tiprankstipranks
Advertisement
Advertisement

XOMA Stock Latest News

XOMA Royalty Reports Strong 2025 Results and Growth
Company AnnouncementsXOMA Royalty Reports Strong 2025 Results and Growth
7d ago
8K
XOMA
Xoma reports Q4 EPS 26c, consensus (13c)
PremiumThe Fly
Xoma reports Q4 EPS 26c, consensus (13c)
7d ago
XOMA
Is XOMA a Buy, Before Earnings?
PremiumPre-Earnings
Is XOMA a Buy, Before Earnings?
22d ago
XOMA
XOMA Highlights Royalty Aggregation Strategy in Updated Presentation
PremiumCompany Announcements
XOMA Highlights Royalty Aggregation Strategy in Updated Presentation
23d ago
8K
XOMA
Xoma price target raised to $50 from $45 at Leerink
PremiumThe Fly
Xoma price target raised to $50 from $45 at Leerink
29d ago
XOMA
XOMA Royalty Completes Generation Bio Acquisition and Merger
PremiumCompany AnnouncementsXOMA Royalty Completes Generation Bio Acquisition and Merger
1M ago
8K
XOMA
XOMA Royalty Appoints New Chief Financial Officer
Premium
Company Announcements
XOMA Royalty Appoints New Chief Financial Officer
2M ago
8K
XOMA
Xoma announces CFO Burns to step down, Trigilio to succeed
Premium
The Fly
Xoma announces CFO Burns to step down, Trigilio to succeed
2M ago
XOMA
XOMA Highlights Royalty Growth Strategy in Updated Presentation
PremiumCompany Announcements
XOMA Highlights Royalty Growth Strategy in Updated Presentation
2M ago
8K
XOMA
H.C. Wainwright remains bullish on Xoma following creative Takeda deal
PremiumThe Fly
H.C. Wainwright remains bullish on Xoma following creative Takeda deal
3M ago
TAK
XOMA
XOMA: Expanding Royalty Portfolio and Capital-Efficient Partnerships Underpin Buy Rating
PremiumRatings
XOMA: Expanding Royalty Portfolio and Capital-Efficient Partnerships Underpin Buy Rating
3M ago
XOMA
Xoma, Takeda execute royalty sharing transaction, amend Mezagitamab agreement
PremiumThe Fly
Xoma, Takeda execute royalty sharing transaction, amend Mezagitamab agreement
3M ago
TAK
XOMA
Strategic Acquisitions and Partnerships Drive Xoma’s Growth: A Buy Recommendation
PremiumRatingsStrategic Acquisitions and Partnerships Drive Xoma’s Growth: A Buy Recommendation
3M ago
XOMA
Generation Bio price target lowered to $5.50 from $7 at Wedbush
Premium
The Fly
Generation Bio price target lowered to $5.50 from $7 at Wedbush
3M ago
GBIO
MRNA
Generation Bio downgraded to Hold from Buy at Jefferies
Premium
The Fly
Generation Bio downgraded to Hold from Buy at Jefferies
3M ago
GBIO
XOMA
Xoma to acquire Generation Bio for $4.2913 per share
PremiumThe Fly
Xoma to acquire Generation Bio for $4.2913 per share
3M ago
GBIO
XOMA
Xoma to acquire Generation Bio for $4.2913 per share
PremiumThe Fly
Xoma to acquire Generation Bio for $4.2913 per share
3M ago
GBIO
XOMA
Buy Rating Maintained for XOMA Despite Rezolute Bio’s Trial Setback, Future Developments Anticipated
PremiumRatings
Buy Rating Maintained for XOMA Despite Rezolute Bio’s Trial Setback, Future Developments Anticipated
3M ago
XOMA
Xoma price target lowered to $97 from $104 at H.C. Wainwright
PremiumThe Fly
Xoma price target lowered to $97 from $104 at H.C. Wainwright
3M ago
XOMA
Xoma’s Resilience and Growth Potential: Analyst Reaffirms Buy Rating Amidst Diversified Portfolio and Strong Financial Health
PremiumRatingsXoma’s Resilience and Growth Potential: Analyst Reaffirms Buy Rating Amidst Diversified Portfolio and Strong Financial Health
3M ago
XOMA
Xoma price target lowered to $45 from $58 at Leerink
Premium
The Fly
Xoma price target lowered to $45 from $58 at Leerink
3M ago
RZLT
XOMA
Xoma falls 21% after partner Rezolute announces trial failure
Premium
The Fly
Xoma falls 21% after partner Rezolute announces trial failure
3M ago
RZLT
XOMA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >